Ashley Brate, Ph.D., is an immunologist and Associate Director at SeromYx Systems, specializing in the systems-level characterization of humoral and cellular immune responses. Her work centers on multiplexed antibody profiling and Fc-effector analysis to identify immune signatures that guide vaccine development and therapeutic optimization.
Ashley’s background spans academic immunology and biotechnology, including research defining suppressive CD8⁺ T-cell subsets in autoimmune disease and industry roles advancing immune monitoring and engineered cell therapy platforms. She brings broad expertise in translating complex immune data into actionable insights for the development of next-generation vaccines and immunotherapies.